The goal of this activity is for learners to be better able to understand the role of novel systemic therapies in improving outcomes for patients with IDH-mutant glioma and recognize the factors impacting their quality of life and overall well-being.
- Provider:Medscape, LLC
- Activity Link: https://www.medscape.org/viewarticle/1001253
- Start Date: 2024-06-28 05:00:00
- End Date: 2024-06-28 05:00:00
- Credit Details: IPCE Credits: 1.25 hours
AMA PRA Category 1 Credit™️: 1.25 hours
Nursing: 1.25 hours - MOC Credit Details: ABIM - 1.25 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: Source: Servier - Amount: 126500.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Medical Oncology
Subscribe
Login
0 Comments
Oldest